3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
33
Brain Neoplasms
21
Carcinoma, Non-Small-Cell Lung
19
Neoplasm Metastasis
17
Lung Neoplasms
15
Carcinoma, Hepatocellular
13
Breast Neoplasms
10
Pancreatic Neoplasms
9
Melanoma
9
Carcinoma, Renal Cell
9
Neoplasms
6
Colorectal Neoplasms
6
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Spinal Cord Neoplasms
3
Small Cell Lung Carcinoma
3
Prostate Cancer Metastatic
3
Nasopharyngeal Carcinoma
3
Kidney Neoplasms
3
Adenocarcinoma
3
Urinary Bladder Neoplasms
2
Unresectable Locally Recurrent Rectal Cancer
2
Sarcoma
2
Radiation Injuries
2
Osteosarcoma
2
Oligometastatic Prostate Cancer
2
Neuroma, Acoustic
2
Neoplasms by Site
2
Klatskin Tumor
2
Head and Neck Neoplasms
2
Interventions
Carboplatin
5
Cisplatin
3
zipalertinib
1
zimberelimab
1
sacituzumab govitecan
1
repotrectinib
1
pembrolizumab
1
cemiplimab
1
atezolizumab
1
alectinib
1
Vital Signs
1
Tomography, Emission-Computed, Single-Photon
1
Toll-Like Receptor 1
1
Telescopes
1
Radiotherapy
1
Radiosurgery
1
Pemetrexed
1
Paclitaxel
1
Magnetic Resonance Spectroscopy
1
Etoposide
1
Drug Delivery Systems
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Lung Diseases
×
Radiosurgery
×
Clear all
NCT02984761
2026-02-19
VALOR
VA Office of Research and Development
Phase NA
Recruiting
670 enrolled